ZA914185B - Method for treating alcoholism with nalmefene - Google Patents
Method for treating alcoholism with nalmefeneInfo
- Publication number
- ZA914185B ZA914185B ZA914185A ZA914185A ZA914185B ZA 914185 B ZA914185 B ZA 914185B ZA 914185 A ZA914185 A ZA 914185A ZA 914185 A ZA914185 A ZA 914185A ZA 914185 B ZA914185 B ZA 914185B
- Authority
- ZA
- South Africa
- Prior art keywords
- nalmefene
- treating alcoholism
- alcoholism
- treating
- alcoholics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/532,424 US5086058A (en) | 1990-06-04 | 1990-06-04 | Method for treating alcoholism with nalmefene |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA914185B true ZA914185B (en) | 1992-07-29 |
Family
ID=24121726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA914185A ZA914185B (en) | 1990-06-04 | 1991-06-03 | Method for treating alcoholism with nalmefene |
Country Status (19)
Country | Link |
---|---|
US (1) | US5086058A (xx) |
EP (1) | EP0531415B1 (xx) |
JP (1) | JP3059213B2 (xx) |
AT (1) | ATE145329T1 (xx) |
AU (1) | AU642748B2 (xx) |
CA (1) | CA2084519C (xx) |
DE (1) | DE69123247T2 (xx) |
DK (1) | DK0531415T3 (xx) |
ES (1) | ES2097209T3 (xx) |
FI (1) | FI925513A0 (xx) |
GR (1) | GR3022289T3 (xx) |
HU (1) | HU210637B (xx) |
IE (1) | IE77333B1 (xx) |
LT (1) | LT3893B (xx) |
LV (1) | LV10190B (xx) |
NZ (1) | NZ238391A (xx) |
RU (1) | RU2090190C1 (xx) |
WO (1) | WO1991018605A1 (xx) |
ZA (1) | ZA914185B (xx) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4882335A (en) * | 1988-06-13 | 1989-11-21 | Alko Limited | Method for treating alcohol-drinking response |
US6271239B1 (en) * | 1992-04-13 | 2001-08-07 | Regents Of The University Of Minnesota | Delta opioid receptor-selective benzylidene-substituted morphinans |
US5352680A (en) * | 1992-07-15 | 1994-10-04 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists to block opioid agonist tolerance and dependence |
USRE36547E (en) * | 1992-09-21 | 2000-02-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists |
US6096756A (en) | 1992-09-21 | 2000-08-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
US5580876A (en) * | 1992-09-21 | 1996-12-03 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
US5298622A (en) * | 1993-05-12 | 1994-03-29 | Regents Of The University Of Minnesota | Spiroindane opiate analogs |
US5457208A (en) | 1993-06-21 | 1995-10-10 | Regents Of The University Of Minnesota | Kappa opioid receptor antagonists |
US5587381A (en) * | 1995-03-27 | 1996-12-24 | Sinclair; John D. | Method for terminating methadone maintenance through extinction of the opiate-taking responses |
WO1997018781A1 (en) * | 1995-11-20 | 1997-05-29 | University Of Miami | Method of treating nicotine dependence |
US5878750A (en) * | 1996-11-14 | 1999-03-09 | Clemens; Anton H. | Method of treating the syndrome of coronary heart disease risk factors in humans |
US5780479A (en) * | 1997-04-04 | 1998-07-14 | Regents Of The University Of Minnesota | Use of opioid antagonists to treat impulse-control disorders |
US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
JP2001526229A (ja) * | 1997-12-22 | 2001-12-18 | ユーロ−セルティーク,エス.エイ. | オピオイド投薬剤形の乱用を防止する方法 |
ES2412409T3 (es) | 1997-12-22 | 2013-07-11 | Euro-Celtique S.A. | Forma farmacéutica para dosificación oral que comprende una combinación de un agonista opiáceo y un antagonista opiáceo |
AU1807401A (en) * | 1999-11-30 | 2001-06-12 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
GEP20053614B (en) | 2000-02-08 | 2005-09-26 | Euro Celtique Sa | Compositions for Oral Administration Containing Opioid Agonist |
US6716449B2 (en) | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
US20040024004A1 (en) * | 2001-05-04 | 2004-02-05 | Sherman Barry M. | Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists |
US6262062B1 (en) * | 2000-08-15 | 2001-07-17 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
US6528520B2 (en) * | 2000-08-15 | 2003-03-04 | Cpd, Llc | Method of treating the syndrome of coronary heart disease risk factors in humans |
US6846831B2 (en) | 2000-08-15 | 2005-01-25 | Cpd, Llc | Method of treating the syndrome of lipodystrophy |
CA2446550C (en) | 2001-05-11 | 2012-03-06 | Endo Pharmaceuticals, Inc. | Abuse-resistant controlled-release opioid dosage form |
JP4736323B2 (ja) * | 2001-07-13 | 2011-07-27 | アークレイ株式会社 | 分析用具を備えた濃度測定装置用の穿刺要素一体装着体、および体液採取用具 |
WO2003007802A2 (en) * | 2001-07-18 | 2003-01-30 | Euro-Celtique, S.A. | Pharmaceutical combinations of oxycodone and naloxone |
AU2002323032B2 (en) | 2001-08-06 | 2005-02-24 | Euro-Celtique S.A. | Opioid agonist formulations with releasable and sequestered antagonist |
US20030044458A1 (en) | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
WO2003013433A2 (en) * | 2001-08-06 | 2003-02-20 | Euro-Celtique S.A. | Sequestered antagonist formulations |
US20030153590A1 (en) * | 2001-08-14 | 2003-08-14 | Oy Contral Pharma Ltd | Method of treating alcoholism or alcohol abuse |
CA2708900C (en) | 2002-04-05 | 2019-06-04 | Purdue Pharma | Pharmaceutical preparation containing oxycodone and naloxone |
US7501433B2 (en) * | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US7923454B2 (en) * | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
SI2561860T1 (en) * | 2002-05-31 | 2018-05-31 | Titan Pharmaceuticals, Inc. | An implantable polymeric device for prolonged release of buprenorphine |
DK1551372T3 (en) * | 2002-09-20 | 2018-07-23 | Alpharma Pharmaceuticals Llc | SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES |
US20050031667A1 (en) | 2003-03-31 | 2005-02-10 | Patel Rajesh A. | Implantable polymeric device for sustained release of dopamine agonist |
US20040202717A1 (en) * | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
CA2522471A1 (en) * | 2003-04-14 | 2004-10-28 | Pain Therapeutics, Inc. | Methods for the treatment of pain comprising opioid antagonists |
MY135852A (en) | 2003-04-21 | 2008-07-31 | Euro Celtique Sa | Pharmaceutical products |
US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
US20060009478A1 (en) * | 2003-10-15 | 2006-01-12 | Nadav Friedmann | Methods for the treatment of back pain |
EP1604666A1 (en) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD) |
EP1702558A1 (en) * | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
EP2526932B1 (en) * | 2006-06-19 | 2017-06-07 | Alpharma Pharmaceuticals LLC | Pharmaceutical composition |
PT2724722T (pt) | 2006-10-20 | 2017-03-14 | Neurendo Pharma Llc | Método de restaurar o efeito incretina |
AU2008346870A1 (en) * | 2007-12-17 | 2009-07-16 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
US20100151014A1 (en) * | 2008-12-16 | 2010-06-17 | Alpharma Pharmaceuticals, Llc | Pharmaceutical composition |
US8623418B2 (en) * | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
DK2291380T3 (da) * | 2008-04-24 | 2011-12-05 | Janssen Pharmaceutica Nv | Nalmefen-prodrugs |
DK2307420T3 (da) * | 2008-04-24 | 2012-02-27 | Janssen Pharmaceutica Nv | Nalmefendiester-prodrugs |
PE20110422A1 (es) * | 2008-07-07 | 2011-07-01 | Euro Celtique Sa | Composicion farmaceutica que comprende antagonistas opioides |
PT2405915T (pt) | 2009-03-10 | 2019-01-29 | Euro Celtique Sa | Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona |
US20140005216A1 (en) | 2012-06-27 | 2014-01-02 | H. Lundbeck A/S | Nalmefene for reduction of alcohol consumption in specific target populations |
WO2014170353A1 (en) * | 2013-04-17 | 2014-10-23 | H. Lundbeck A/S | Nalmefene for treatment of patients with sleep disorder |
EP3024461B1 (en) | 2013-07-23 | 2020-05-13 | Euro-Celtique S.A. | A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation |
CN106456634A (zh) * | 2014-04-22 | 2017-02-22 | 大塚制药株式会社 | 布雷帕唑和纳美芬的组合及其用于治疗物质有关的病症的用途 |
ES2787223T3 (es) | 2014-11-07 | 2020-10-15 | Univ Minnesota | Sales y composiciones útiles para tratar enfermedades |
WO2017184819A1 (en) * | 2016-04-22 | 2017-10-26 | Taiwanj Pharmaceuticals Co., Ltd. | Nalmefene, naltrexone or derivatives thereof for use in treating (non)-alcoholic steatohepatitis or non-alcoholic fatty liver disease |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4882335A (en) * | 1988-06-13 | 1989-11-21 | Alko Limited | Method for treating alcohol-drinking response |
US4857533A (en) * | 1988-12-15 | 1989-08-15 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for autoimmune diseases |
US4863928A (en) * | 1989-01-04 | 1989-09-05 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for arthritic and inflammatory diseases |
US5096715A (en) * | 1989-11-20 | 1992-03-17 | Alko Ltd. | Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist |
-
1990
- 1990-06-04 US US07/532,424 patent/US5086058A/en not_active Expired - Lifetime
-
1991
- 1991-05-10 EP EP91910595A patent/EP0531415B1/en not_active Expired - Lifetime
- 1991-05-10 DK DK91910595.7T patent/DK0531415T3/da active
- 1991-05-10 WO PCT/US1991/003241 patent/WO1991018605A1/en active IP Right Grant
- 1991-05-10 ES ES91910595T patent/ES2097209T3/es not_active Expired - Lifetime
- 1991-05-10 DE DE69123247T patent/DE69123247T2/de not_active Expired - Lifetime
- 1991-05-10 CA CA002084519A patent/CA2084519C/en not_active Expired - Lifetime
- 1991-05-10 JP JP3509984A patent/JP3059213B2/ja not_active Expired - Lifetime
- 1991-05-10 RU RU9192016403A patent/RU2090190C1/ru active
- 1991-05-10 HU HU9203835A patent/HU210637B/hu unknown
- 1991-05-10 AU AU79740/91A patent/AU642748B2/en not_active Expired
- 1991-05-10 AT AT91910595T patent/ATE145329T1/de not_active IP Right Cessation
- 1991-06-03 ZA ZA914185A patent/ZA914185B/xx unknown
- 1991-06-04 IE IE188891A patent/IE77333B1/en not_active IP Right Cessation
- 1991-06-04 NZ NZ238391A patent/NZ238391A/en not_active IP Right Cessation
-
1992
- 1992-12-04 FI FI925513A patent/FI925513A0/fi unknown
-
1993
- 1993-08-31 LV LVP-93-1052A patent/LV10190B/en unknown
- 1993-11-25 LT LTIP1486A patent/LT3893B/lt not_active IP Right Cessation
-
1997
- 1997-01-16 GR GR960403307T patent/GR3022289T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2097209T3 (es) | 1997-04-01 |
US5086058A (en) | 1992-02-04 |
FI925513A (fi) | 1992-12-04 |
HUT65523A (en) | 1994-06-28 |
NZ238391A (en) | 1997-06-24 |
LTIP1486A (en) | 1995-09-25 |
DK0531415T3 (da) | 1996-12-09 |
AU7974091A (en) | 1991-12-31 |
IE911888A1 (en) | 1991-12-04 |
HU9203835D0 (en) | 1993-03-29 |
LT3893B (en) | 1996-04-25 |
CA2084519C (en) | 1999-02-09 |
AU642748B2 (en) | 1993-10-28 |
HU210637B (en) | 1995-06-28 |
WO1991018605A1 (en) | 1991-12-12 |
EP0531415B1 (en) | 1996-11-20 |
JP3059213B2 (ja) | 2000-07-04 |
CA2084519A1 (en) | 1991-12-05 |
EP0531415A1 (en) | 1993-03-17 |
LV10190A (lv) | 1994-10-20 |
DE69123247T2 (de) | 1998-01-15 |
IE77333B1 (en) | 1997-12-03 |
GR3022289T3 (en) | 1997-04-30 |
JPH06506665A (ja) | 1994-07-28 |
RU2090190C1 (ru) | 1997-09-20 |
LV10190B (en) | 1995-06-20 |
FI925513A0 (fi) | 1992-12-04 |
ATE145329T1 (de) | 1996-12-15 |
DE69123247D1 (de) | 1997-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3022289T3 (en) | Method for treating alcoholism with nalmefene | |
RU92016403A (ru) | Способ лечения алкоголизма налмефеном | |
MXPA99001239A (es) | Proceso mejorado para la produccion de bebidas alcoholicas que utilizan semilla de malta. | |
EP0825196A3 (en) | Enzyme-treated hesperidin, process for producing the same and method of using enzyme-treated hesperidin | |
AU3838097A (en) | Process for the production of alcholic coffee drinks | |
ZA957645B (en) | A method for production of ethyl alcohol | |
EP0629879A3 (de) | Verfahren zum Bestimmen von Tiefenwerten eines Gewässers. | |
ZA9472B (en) | Process for producing low molecular-weight poly-1-olefins. | |
GR3015586T3 (en) | Process for producing fuel oil and gas by cracking waste rubber. | |
MY119686A (en) | Sequential distillation process for removing tetrahydroazepine from aminocapronitrile and/or hexamethylenediamine | |
AU5102490A (en) | Process of treating alcoholic beverages by vapor-arbitrated pervaporisation | |
ZA943254B (en) | A process to increase the water vapour permeability of leather, especialy for application in the automobile industry. | |
HUT60202A (en) | Method for producing cork stopper | |
AU3258993A (en) | Method for producing BIS-pyridinic derivatives with acetylcholinesterase inhibiting properties | |
HUT75184A (en) | Plastisol, process for producing thereof and uses thereof | |
GR3024442T3 (en) | Method to purify streptolysin o, intact streptolysin o obtainable by this method and its use | |
AU7275994A (en) | Process for producing emulsion fuel | |
HUT64765A (en) | Method for producing oxa-bicyclo[2.2.1] heptane-2,3-dimethanol-derivatives | |
AU2767192A (en) | Process for producing chloroisocyanurates with hypochlorous acid | |
NO950978D0 (no) | Polyolefinbasert pigmentert blanding, samt fremgangsmåte for fremstilling av tilformede gjenstander med utgangspunkt i blandingen | |
EP0633263A3 (en) | Process for the preparation of thiophene derivatives. | |
HU9400262D0 (en) | Process for producing sparkling drinks | |
HU9400762D0 (en) | Process for producing intermediate | |
HU9301383D0 (en) | Method for producing drink concentrates | |
LV10483B (en) | Process for producing sparkling wines |